Detalhe da pesquisa
1.
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City.
J Oncol Pharm Pract
; 27(2): 389-394, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459159
2.
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
J Neurooncol
; 145(1): 57-63, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432377
3.
Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia.
Ann Hematol
; 95(12): 2009-2015, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542957
4.
Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort.
Ann Lymphoma
; 72023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067886
5.
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Leuk Lymphoma
; 63(3): 627-632, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758711
6.
Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma.
CNS Oncol
; 7(3): CNS19, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30221993
7.
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.
J Immunother Cancer
; 5(1): 99, 2017 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254497